{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:40:12Z","timestamp":1783510812093,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.lfs.2024.122674","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T05:45:28Z","timestamp":1714369528000},"page":"122674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1"],"prefix":"10.1016","volume":"348","author":[{"given":"Fengling","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10272","key":"10.1016\/j.lfs.2024.122674_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lfs.2024.122674_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/gutjnl-2020-322493","article-title":"Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma","volume":"71","author":"Aoki","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.lfs.2024.122674_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001240","article-title":"Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial","volume":"8","author":"Chen","year":"2020","journal-title":"J. ImmunoTher. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2024.122674_bb0030","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jamaoncol.2018.3277","article-title":"Nab-paclitaxel and gemcitabine as first-line treatment of advanced or metastatic cholangiocarcinoma: a phase 2 clinical trial","volume":"4","author":"Sahai","year":"2018","journal-title":"JAMA Oncol."},{"issue":"13","key":"10.1016\/j.lfs.2024.122674_bb0035","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41388-018-0590-8","article-title":"USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis","volume":"38","author":"Ma","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13046-019-1227-7","article-title":"Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide","volume":"38","author":"Xia","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122674_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095053","article-title":"Ubiquitin and ubiquitin-like proteins in cancer, neurodegenerative disorders, and heart diseases","volume":"23","author":"Hwang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122674_bb0050","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jcmm.14813","article-title":"Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.lfs.2024.122674_bb0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41419-021-04356-6","article-title":"USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1","volume":"12","author":"Pan","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.lfs.2024.122674_bb0060","first-page":"2284","article-title":"Overexpression of USP5 contributes to tumorigenesis in non-small cell lung cancer via the stabilization of \u03b2-catenin protein","volume":"8","author":"Ma","year":"2018","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122674_bb0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7150\/thno.27654","article-title":"USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma","volume":"9","author":"Meng","year":"2019","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.lfs.2024.122674_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.450","article-title":"Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2024.122674_bb0075","article-title":"USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122674_bb0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cac2.12403","article-title":"METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"43","author":"Xia","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"14","key":"10.1016\/j.lfs.2024.122674_bb0085","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.7150\/thno.33803","article-title":"Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0090","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1038\/s41598-023-35793-2","article-title":"A pan-cancer analysis of the role of USP5 in human cancers","volume":"13","author":"Yan","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2024.122674_bb0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2021.10.009","article-title":"Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection","volume":"76","author":"Herta","year":"2022","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.lfs.2024.122674_bb0100","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","article-title":"KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma","volume":"42","author":"Jiang","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gendis.2017.12.005","article-title":"SOX4 contributes to TGF-\u03b2-induced epithelial-mesenchymal transition and stem cell characteristics of gastric cancer cells","volume":"5","author":"Peng","year":"2018","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.lfs.2024.122674_bb0110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.7150\/ijbs.23845","article-title":"WDR1 promotes cell growth and migration and contributes to malignant phenotypes of non-small cell lung cancer through ADF\/cofilin-mediated actin dynamics","volume":"14","author":"Yuan","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122674_bb0115","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41401-021-00704-6","article-title":"Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling","volume":"43","author":"Ning","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.lfs.2024.122674_bb0120","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/15548627.2021.1965426","article-title":"USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3","volume":"18","author":"Cai","year":"2022","journal-title":"Autophagy"},{"issue":"18","key":"10.1016\/j.lfs.2024.122674_bb0125","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1111\/febs.15828","article-title":"FBXW8 regulates G1 and S phases of cell cycle progression by restricting \u03b2-TrCP1 function","volume":"288","author":"Islam","year":"2021","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.lfs.2024.122674_bb0130","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.21037\/tlcr-21-767","article-title":"Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122674_bb0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","article-title":"Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks","volume":"66","author":"Vaquero","year":"2017","journal-title":"J. Hepatol."},{"issue":"23","key":"10.1016\/j.lfs.2024.122674_bb0140","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-21-1538","article-title":"A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression","volume":"81","author":"Liang","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2024.122674_bb0145","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ymthe.2021.02.017","article-title":"WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1\u03b1 accumulation in Myc-dependent and independent pathways","volume":"29","author":"Chen","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2024.122674_bb0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphar.2020.00668","article-title":"USP5 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition via Wnt\/\u03b2-catenin pathway","volume":"11","author":"Xue","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","article-title":"Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription","volume":"76","author":"Chen","year":"2022","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122674_bb0160","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.32483","article-title":"Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2024.122674_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.gendis.2015.05.001","article-title":"Role of post-translational modification of the Y box binding protein 1 in human cancers","volume":"2","author":"Prabhu","year":"2015","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010104","article-title":"Inhibition of transcription induces phosphorylation of YB-1 at Ser102 and its accumulation in the nucleus","volume":"9","author":"Kretov","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.lfs.2024.122674_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2009.03.017","article-title":"Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition","volume":"15","author":"Evdokimova","year":"2009","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.lfs.2024.122674_bb0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccr.2009.04.006","article-title":"YB-1 translational control of epithelial-mesenchyme transition","volume":"15","author":"Mouneimne","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2024.122674_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2017.03.001","article-title":"Emerging role of DUBs in tumor metastasis and apoptosis: therapeutic implication","volume":"177","author":"He","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2024.122674_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.lfs.2024.122674_bb0195","first-page":"3151","article-title":"Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer","volume":"7","author":"Shibahara","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122674_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.omto.2020.03.006","article-title":"Overexpression of YBX1 promotes pancreatic ductal adenocarcinoma growth via the GSK3B\/cyclin D1\/cyclin E1 pathway","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13046-022-02346-w","article-title":"Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"25","key":"10.1016\/j.lfs.2024.122674_bb0210","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","article-title":"Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice","volume":"139","author":"Huang","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.lfs.2024.122674_bb0215","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215132120","article-title":"circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-022-00387-6","article-title":"SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1","volume":"11","author":"Gao","year":"2022","journal-title":"Oncogenesis"},{"issue":"23","key":"10.1016\/j.lfs.2024.122674_bb0230","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.7150\/thno.47830","article-title":"LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.lfs.2024.122674_bb0235","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/gtc.12150","article-title":"YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers","volume":"19","author":"Harada","year":"2014","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13046-022-02452-9","article-title":"LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122674_bb0245","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-05-3561","article-title":"Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122674_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-019-1493-4","article-title":"BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition","volume":"39","author":"Niu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.lfs.2024.122674_bb0255","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/sj.onc.1208590","article-title":"Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells","volume":"24","author":"Sutherland","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lfs.2024.122674_bb0260","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/cas.14006","article-title":"Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer","volume":"110","author":"Kuwano","year":"2019","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122674_bb0265","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41556-022-00857-4","article-title":"Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway","volume":"24","author":"Lv","year":"2022","journal-title":"Nat. Cell Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T11:51:14Z","timestamp":1716119474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524002649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"alternative-id":["S0024320524002649"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122674","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122674"}}